Search
for
Sort by
Research 421–450 of 1000+
- Basal cell carcinoma of the scalp shows distinct features from the face in Asians
- Children with trichotillomania in COVID‐19 outbreak
- THE FREQUENCY OF VISCERAL AND PHENOTYPIC MARKERS IN PATIENTS WITH THE COMBINATION OF UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE AND GASTROESOPHAGEAL REFLUX DISEASE
- Leprosy on the scalp
- Hair loss and its management in children
- A retrospective review of 12 patients with trichotillomania treated in a psychodermatology service
- Adipose tissue transplant in recurrent folliculitis decalvans
- Secondary amenorrhea
- Topical minoxidil and tretinoin combined with an oral vitamin D analog as a treatment for woolly hair
- Commentary: Hair Transplantation and Female Hairlines
- Low-Level Laser Therapy (LLLT) in Wound Healing
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Disorders of ovulation
- Results of 60-second timed hair counts in women between the ages of 20–60 years
- Fibrosing Alopecia in a Pattern Distribution
- Scarring Alopecia
- Clinical Manifestation and Classification of Japanese patients with Inherited Keratinizing Disorders
- Primary cicatricial alopecias
- Alopecia Areata is associated with MICA and an extended HLA haplotype
- The Association between Low (or Reduced) Circulating Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 with Hair Loss in Women. A Case-Control Study in Basrah, Iraq
- Trichotillomania in Childhood: A Case Report
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Research on the Mechanism of Hair Dyeing Agents and Strategies for Health Risks Reduction
- Tufted Hair Folliculitis Decalvans as a Clinical Diagnostic Sign
- BH11 Cutis verticis gyrata associated with chronic traction
- SERUM PROLACTIN LEVELS IN WOMEN HAVING HIRSUTISM
- Scaly Papular Lesions
- Folliculitis decalvans and orofacial granulomatosis
- Trichotillomania and Traction Alopecia
- 423 Short-Acting Intramuscular Testosterone Delivered in the Clinic Setting Remains a Key Patient-Friendly and Patient-Directed Option in the Contemporary Management of Hypogonadism